Sigma-Aldrich (Nasdaq: SIAL) has acquired ChemNavigator Inc., a San Diego-based provider of discovery research informatics software tools for the design, selection and procurement of chemical compound libraries. No financial terms were disclosed. ChemNavigator raised VC funding in 2000 from AsiaVest Partners, 3V SourceOne Capital, Castle Rock Ventures, Chitung Venture Capital, Global Life Science Ventures, Hotung International, UOB Venture Management and Taurus Enterprises.
3 min read · 07 August 2009
Atrinsic Inc. (Nasdaq: ATRN) has acquired ShopIt.com, a Brentwood, Calif.-based e-commerce platform that allows buyers and sellers to tap into social networks like Facebook. No financial terms were disclosed. ShopIt had raised a small amount of VC funding from Propulsion Ventures and Helios Investment Partners.
3 min read · 07 August 2009
1 min read · 07 August 2009
Arcion Therapeutics, a Baltimore-based biotech company focused on alleviating pain associated with diabetic neuropathy, has agreed to go public via a reverse merger with Anesiva Inc. (Nasdaq: ANSV). Simultaneously, the combined company plans to raise $20 million in new equity. Following the transaction, Arcion shareholders will hold a 64% stake. Arcion has raised over $17 million in VC funding from firms like CMEA Capital and InterWest Partners.
6 min read · 06 August 2009
Broadview Networks Inc., a Rye Brook, N.Y.-based provider of integrated communications and managed security services, has agreed to acquire select assets of Natural Convergence Inc., an Ottawa-based provider of hosted VoIP software applications. No financial terms were disclosed. Broadview has raised nearly $300 million in total VC funding since 1997, with current shareholders including Baker Capital, MCG Capital, New Enterprise Associates, ComVentures and Lightspeed Venture Partners. Natural Convergence has raised VC funding from firms like VIMAC Ventures, Jefferson Partners, BDC Venture Capital, Dejardins, Primaxis, WesleyClover and PurpleAngel.
3 min read · 06 August 2009
3-V Biosciences, a Palo Alto, Calif.-based pharma startup whose lead candidates focus on respiratory viral infections, has raised $30 million in Series B funding. New Enterprise Associates led the round, and was joined by return backers The Column Group and Kleiner Perkins Caufield & Byers.
3 min read · 06 August 2009
1 min read · 05 August 2009
2 min read · 05 August 2009
Questar Assessment Inc., an Apple Valley, Minn.-based provider of educational assessments for states, has raised $4.6 million in VC funding from Camden Partners and New Markets Venture Partners.
3 min read · 05 August 2009
1 min read · 05 August 2009
